KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $28.1 billion.

  • Bristol Myers Squibb's Total Current Liabilities rose 2428.66% to $28.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 billion, marking a year-over-year increase of 2428.66%. This contributed to the annual value of $23.8 billion for FY2024, which is 679.18% up from last year.
  • Bristol Myers Squibb's Total Current Liabilities amounted to $28.1 billion in Q3 2025, which was up 2428.66% from $27.5 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Total Current Liabilities peaked at $28.1 billion during Q3 2025, and registered a low of $17.3 billion during Q1 2021.
  • For the 5-year period, Bristol Myers Squibb's Total Current Liabilities averaged around $22.3 billion, with its median value being $22.3 billion (2023).
  • As far as peak fluctuations go, Bristol Myers Squibb's Total Current Liabilities crashed by 1891.46% in 2021, and later surged by 3530.0% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Total Current Liabilities stood at $21.9 billion in 2021, then rose by 0.1% to $21.9 billion in 2022, then rose by 1.7% to $22.3 billion in 2023, then increased by 6.79% to $23.8 billion in 2024, then grew by 18.35% to $28.1 billion in 2025.
  • Its Total Current Liabilities was $28.1 billion in Q3 2025, compared to $27.5 billion in Q2 2025 and $24.1 billion in Q1 2025.